Home Breakthrough in Genomic Medicine: 26-Hour Genetic Diagnosis Platform Sets World Record

Breakthrough in Genomic Medicine: 26-Hour Genetic Diagnosis Platform Sets World Record

May 01, 2016 08:00 CST Updated 08:00

In the field of genetics, April 25 is a special date: 63 years ago on this day, the double-helix structure of DNA was discovered for the first time; 13 years ago on this day, the Human Genome Project was officially declared complete. And on this day this year, a Guinness World Record—the record for the fastest gene sequencing—was set in San Diego, USA, known as the “World Capital of Genomics.” The record was created by Dr. Stephen Kingsmore, current President and CEO of the Institute for Genomic Medicine at Rady Children’s Hospital. Previously, while serving at Children’s Mercy in Kansas City, he successfully used genomic sequencing technology to diagnose diseases in infants with severe birth defects within 26 hours. This remains the fastest genetic diagnosis ever achieved worldwide.


Behind this record lies significant progress in gene sequencing and diagnostic capabilities. Dr. Stephen Kingsmore employed Edico Genome’s bioinformatics data processing platform, known as “DRAGEN,” alongside Illumina’s high-throughput sequencing instruments. Furthermore, optimization of certain parameters during the sequencing process also played a role.


“Diagnosing infants with severe birth defects is essentially a race against time to save lives, which is why physicians need methods that can deliver diagnostic conclusions and help formulate treatment plans in the shortest possible time,” said Dr. Kingsmore in an interview (see video). “With molecular genetic testing tools, we can provide precise, targeted therapies for these patients. Today, thanks to technological advancements, we have finally achieved the ability to complete genetic diagnosis in just 26 hours—a truly remarkable feat. It is important to recognize that for at least dozens of conditions, even a one-day earlier diagnosis could mean the difference between life and death.”“At present, a key objective for us is to scale up this rapid diagnostic approach. We urgently need a capability to perform genetic diagnoses on hundreds of children simultaneously each day, as we cannot predict which of these patients will require an immediate diagnostic result. The ‘Dragon’ bioinformatics data processing platform is an excellent technology that significantly reduces the time required for genomic data analysis.”

负责这项研究的Kingsmore博士 

“We also need to consider which medical fields currently have the greatest need for such rapid genetic diagnostic technologies. Infants with congenital birth defects in intensive care units certainly have a critical need. In addition, cancer patients urgently require these diagnostic tools, both at initial diagnosis and upon recurrence. Genetic mutations present in tumors are of significant importance in guiding the formulation of treatment plans.”


In the United States, one-third of newborns admitted to intensive care units suffer from genetic disorders, and one-fifth of neonatal deaths are attributable to genetic factors. On the other hand, treatments are currently available for more than 500 genetic conditions, approximately 70 of which can be effectively prevented from progressing to disability or life-threatening disease if detected at birth and managed with appropriate interventions. Today, the cost of whole-genome sequencing has decreased significantly, reaching a level feasible for clinical application. Furthermore, bioinformatics data processing platforms such as “Long” have substantially reduced the time required for genomic data analysis. These technological advancements have enabled the application of gene sequencing in emergency settings.


“As a global leader in the field of DNA sequencing, Illumina has achieved many firsts. However, regarding this historic breakthrough, Illumina is honored to have been part of it.” said Dr. Kevin Hall, Senior Director of Illumina’s Sequencing Systems Division. “We congratulate Dr. Kingsmore, the team at Edico Genome, and everyone who has worked hard in this direction.”“Analysis of big data from gene sequencing often takes a considerable amount of time, which has increasingly become a major obstacle to the advancement of genomic medicine. For infants with severe birth defects, in particular, time is life,” said Dr. Pieter van Rooyen, CEO of Edico Genome. “We appreciate Dr. Kingsmore’s tireless efforts on behalf of infants with birth defects and their families. We are proud that our ‘Dragon’ bioinformatics data processing platform has played a role in this milestone in the development of genomic technology.”References:
[1] Dr. Stephen Kingsmore Sets Guinness World Records Title for Fastest Genetic DiagnosisSource: WuXi AppTec